126 related articles for article (PubMed ID: 11999573)
1. Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells.
Chow KU; Boehrer S; Bojunga J; Stieler M; Rummel MJ; Fauth F; Schneider B; Martin H; Hoelzer D; Weidmann E; Mitrou PS
Leuk Lymphoma; 2002 Feb; 43(2):377-84. PubMed ID: 11999573
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia.
Schirmer M; Geisen F; Tiefenthaler M; Konwalinka G
Leuk Res; 1999 Dec; 23(12):1121-6. PubMed ID: 10613357
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
[TBL] [Abstract][Full Text] [Related]
5. 2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).
Gruber J; Geisen F; Sgonc R; Egle A; Villunger A; Boeck G; Konwalinka G; Greil R
Stem Cells; 1996 May; 14(3):351-62. PubMed ID: 8724701
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic regulation in primitive hematopoietic precursors.
Peters R; Leyvraz S; Perey L
Blood; 1998 Sep; 92(6):2041-52. PubMed ID: 9731062
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone.
Chow KU; Rummel MJ; Weidmann E; Ries J; Jantschke P; Boehrer S; Pourebrahim F; Napieralski S; Stein J; Martin H; Hoelzer D; Mitrou PS
Leuk Lymphoma; 2000 Feb; 36(5-6):559-67. PubMed ID: 10784401
[TBL] [Abstract][Full Text] [Related]
8. Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.
Tiefenthaler M; Hohla F; Strasser-Wozak E; Bacher N; Mühlmann O; Wein W; Konwalinka G
Stem Cells; 2003; 21(3):266-71. PubMed ID: 12743321
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
Csoka K; Liliemark J; Larsson R; Nygren P
Semin Oncol; 1995 Aug; 22(4 Suppl 11):47-53. PubMed ID: 7481845
[TBL] [Abstract][Full Text] [Related]
10. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
11. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
12. Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
Lech-Marańda E; Korycka A; Robak T
Eur J Haematol; 2000 Nov; 65(5):317-21. PubMed ID: 11092462
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood.
Roecklein BA; Reems J; Rowley S; Torok-Storb B
Biol Blood Marrow Transplant; 1998; 4(2):61-8. PubMed ID: 9763108
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia.
Raaijmakers MH; de Grouw EP; van der Reijden BA; de Witte TJ; Jansen JH; Raymakers RA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3452-8. PubMed ID: 16740770
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
16. CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X.
Kim SZ; Zollner TM; Schui DK; Chow KU; Sterry W; Kriener S; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2003 Feb; 44(2):281-9. PubMed ID: 12688346
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
Xiao M; Oppenlander BK; Dooley DC
Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells.
Chow KU; Ries J; Weidmann E; Pourebrahim F; Napieralski S; Stieler M; Boehrer S; Rummel MJ; Stein J; Hoelzer D; Mitrou PS
Ann Hematol; 2000 Sep; 79(9):485-92. PubMed ID: 11043419
[TBL] [Abstract][Full Text] [Related]
19. Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro.
Muench MO; Bárcena A; Ohkubo T; Harrison MR
Cytotherapy; 1999; 1(6):455-68. PubMed ID: 20426546
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.
Josefsen D; Myklebust JH; Lynch DH; Stokke T; Blomhoff HK; Smeland EB
Exp Hematol; 1999 Sep; 27(9):1451-9. PubMed ID: 10480436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
